Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16− Monocytes From COVID-19 Patients
Silvia Lucena Lage, Eduardo P. Amaral, Kerry L. Hilligan, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study
Hussein Kadhem Al‐Hakeim, Haneen Tahseen Al-Rubaye, Dhurgham Shihab Al-Hadrawi, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 2, pp. 564-578
Open Access | Times Cited: 139
Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C
Claudia Vollbracht, Karin Kraft
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 110
Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment
Brian Epling, Joseph M. Rocco, Kristin L. Boswell, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 4, pp. 573-581
Open Access | Times Cited: 42
Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms
Brent Brown, Vanshika Ojha, Ingo Fricke, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 37
Uncoupled pyroptosis and IL-1β secretion downstream of inflammasome signaling
Yang Li, Qianzhou Jiang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 34
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis
Nicola Potere, Evan Garrad, Yogendra Kanthi, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 11, pp. 2046-2060
Open Access | Times Cited: 31
SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19
Joseph W. Guarnieri, Jeffrey Haltom, Yentli E. Soto Albrecht, et al.
Pharmacological Research (2024) Vol. 204, pp. 107170-107170
Open Access | Times Cited: 13
Inflammasome Activation by RNA Respiratory Viruses: Mechanisms, Viral Manipulation, and Therapeutic Insights
Tamara Silva Rodrigues, Dario S. Zamboni
Immunological Reviews (2025) Vol. 330, Iss. 1
Closed Access | Times Cited: 1
Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19
Jessica Gambardella, Urna Kansakar, Celestino Sardu, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 109-115
Open Access | Times Cited: 38
Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease
Carlos A. Labarrere, Ghassan S. Kassab
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 36
Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?
Xing Chang, Nur Izzah Ismail, Attaur Rahman, et al.
Antioxidants and Redox Signaling (2022)
Open Access | Times Cited: 31
Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19
Elisa Brauns, Abdulkader Azouz, David Grimaldi, et al.
JCI Insight (2022) Vol. 7, Iss. 9
Open Access | Times Cited: 30
Ginkgo Biloba and Long COVID: In Vivo and In Vitro Models for the Evaluation of Nanotherapeutic Efficacy
Thelma Akanchise, Angelina Angelova
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1562-1562
Open Access | Times Cited: 17
Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology
Man Wang, Fei Yu, Wenguang Chang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Vaccination reduces central nervous system IL-1β and memory deficits after COVID-19 in mice
Abigail Vanderheiden, Jeremy Hill, Xiaoping Jiang, et al.
Nature Immunology (2024) Vol. 25, Iss. 7, pp. 1158-1171
Closed Access | Times Cited: 8
Inflammasome activation in patients with Kaposi sarcoma herpesvirus (KSHV)-associated disorders
Silvia Lucena Lage, Ramya Ramaswami, Joseph M. Rocco, et al.
Blood (2024) Vol. 144, Iss. 14, pp. 1496-1507
Closed Access | Times Cited: 8
SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147
Shaimaa Shouman, Nada Elkholy, Alaa E. Hussien, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Intrinsic factors behind long COVID: IV. Hypothetical roles of the SARS‐CoV‐2 nucleocapsid protein and its liquid–liquid phase separation
Ahmed Eltayeb, Faisal Al‐Sarraj, Mona G. Alharbi, et al.
Journal of Cellular Biochemistry (2024) Vol. 125, Iss. 3
Closed Access | Times Cited: 6
Molecular Mechanisms Related to Responses to Oxidative Stress and Antioxidative Therapies in COVID-19: A Systematic Review
Evangelia Eirini Tsermpini, Una Glamočlija, Fulden Ulucan‐Karnak, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1609-1609
Open Access | Times Cited: 28
The Role of Glutathione in Prevention of COVID-19 Immunothrombosis: A Review
Ira Glassman, Nghia Le, Mercedeh Mirhosseini, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 3, pp. 59-59
Open Access | Times Cited: 16
Mycobacterial Immune Reconstitution Inflammatory Syndrome in HIV is Associated With Protein-Altering Variants in Hemophagocytic Lymphohistiocytosis-Related Genes
Joseph M. Rocco, Elizabeth Laidlaw, Frances Galindo, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 2, pp. 111-115
Open Access | Times Cited: 13
Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
Roberta Rovito, Matteo Augello, Assaf Ben-Haim, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Neurological damages in COVID‐19 patients: Mechanisms and preventive interventions
Sibani Sarkar, Subhajit Karmakar, Malini Basu, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 13
Do the oxidative stress biomarkers predict COVID-19 outcome? An in-hospital cohort study
Fábio Fernandes Neves, Henrique Pott, Kaori Maria Carolina Yamashita, et al.
Free Radical Biology and Medicine (2023) Vol. 207, pp. 194-199
Closed Access | Times Cited: 11
Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies
Martin Heil
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top